The worldwide cardiac point-of-care (POC) market is expected to grow from its estimated USD 1,680.70 million in 2022 to USD 3,608.90 million by the end of 2030, according to a Zion Market Research analysis. Over the course of the projected period, the market is anticipated to grow at a CAGR of 10.02%. The study examines the factors that will propel growth, impede it, and affect demand for cardiac point-of-care (POC) products worldwide throughout the course of the projection period. Additionally, it will aid in navigating and investigating the prospects that present themselves in the cardiac point-of-care (POC) market.
Global Cardiac Point-of-Care (POC) Market: Overview
One kind of blood test called a cardiac POC also tests for coagulation and cholesterol. When a person has a serious heart condition, an enzyme is secreted, and cardiac POC aids in detecting this. Enzymes can be lactate, brain natriuretic peptides, troponin, and dehydrogenase isoenzymes. Additionally useful in identifying other illnesses like angina and myocardial infarction are cardiac POCs. The indicators that are released when the heart fails are precisely described by the cardiac POC. The test reduces turnaround times, which aids in early detection.
Get a Free Sample : https://www.zionmarketresearch.com/sample/cardiac-point-care-poc-market
Global Cardiac Point-of-Care (POC) Market: Growth Factors
The rising number of cardiac patients and the growing need for these diseases to be diagnosed are some of the factors propelling the expansion of the cardiac point-of-care (POC) market. Additionally, the market is expanding due to the reduction in turnaround times and increased accessibility of technologically sophisticated products with improved features like automation and miniaturisation.
Issues with reimbursement and a downturn in the economy are impeding the expansion of the cardiac point-of-care (POC) business. The absence of exact measures for identifying the presence of cardiovascular illnesses is one of the market’s problems.
The launch of innovative products, market participants’ mergers and acquisitions, and the growth of diagnostic facilities are examples of
Global Cardiac Point-of-Care (POC) Market: Segmentation
Based on the type of device, the cardiac point-of-care (POC) market is divided into segments. The market is divided into cardiac POC testing analyzers and cardiac POC test kits based on the type of device. The creatine kinase-myoglobin (CK-MB), brain natriuretic peptide (BNP), hybrid, biomarker, myoglobin, cardiac troponin, and myoglobin biomarker tests are the other categories under which the cardiac POC test kits are separated.
Global Cardiac Point-of-Care (POC) Market: Regional Analysis
The cardiac point-of-care (POC) market is dominated by North America, with Europe following closely behind. The market is being driven primarily by three factors: an increase in cardiac patients, a growing demand for home healthcare, and supportive government regulations. Additional factors driving the market’s expansion include progressive healthcare reforms, early adoption of cutting-edge technologies, sophisticated healthcare infrastructure, extensive upgrades to the Clinical Laboratory Improvement Amendments (CLIA) waived measures, and heightened patient awareness of health issues. A greater emphasis on the development of linked healthcare, a rise in the prevalence of chronic illnesses, and the rising demand for POC testing equipment are all factors that are positively affecting the European cardiac point-of-care (POC) market.
Directly Purchase a copy of the report with TOC @
https://www.zionmarketresearch.com/toc/cardiac-point-care-poc-market
Global Cardiac Point-of-Care (POC) Market: Competitive Players
Some of the most important market players in the cardiac point-of-care (POC) market include :
- Alere Inc.
- Boston Scientific Corp.
- Abbott Laboratories
- Roche Diagnostics
- Medtronic Inc.,
- among others.
The global Cardiac Point-of-Care (POC) Market is segmented as follows:
By Device Type
- cardiac POC testing analyzer and
- cardiac POC test kits
By further sub-divided
- biomarker test
- myoglobin biomarker test
- myoglobin biomarker test
- cardiac troponin biomarker test
- hybrid test
- creatine kinase-myoglobin (CK-MB)
- and brain natriuretic peptide (BNP) test
Global Cardiac Point-of-Care (POC) Market: Regional Segment Analysis
- North AmericaThe U.S.
- EuropeThe UKFranceGermany
- The Asia PacificChinaJapanIndia
- Latin AmericaBrazil
- The Middle East and Africa
What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651
Newark: 1 (302) 444-0166
India: +91 7768 006 007, +91 7768 006 008
Skype no: +13479038971, +17187054574
Skype no. United Kingdom: +442032894158
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
read other reports :
https://www.linkedin.com/pulse/emotion-detection-recognition-market-size-insights-share-future-wggcf
https://www.linkedin.com/pulse/global-femtech-market-size-research-report-2023-projections-izglf
https://www.linkedin.com/pulse/building-information-modeling-market-size-share-ejs1f
https://www.linkedin.com/pulse/high-speed-document-scanner-market-size-2023-z7duf